Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 30,758 | 38,319 | 20,575 | 11,758 | 8,467 |
| Depreciation Amortization | 3,775 | 4,706 | 4,772 | 4,525 | 4,002 |
| Income taxes - deferred | -747 | 815 | 2,206 | -10 | 1,990 |
| Accounts receivable | -4,996 | 898 | 2,411 | -4,271 | -2,998 |
| Accounts payable and accrued liabilities | 5,625 | -750 | 623 | -2,879 | -6,594 |
| Other Working Capital | 2,955 | 3,779 | -2,921 | -9,473 | -6,962 |
| Other Operating Activity | 2,541 | -7,789 | -2,501 | 10,900 | 12,268 |
| Operating Cash Flow | $39,911 | $39,978 | $25,165 | $10,549 | $10,173 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -21,001 | -6,750 | N/A | N/A | N/A |
| PPE Investments | -9,225 | -1,553 | -253 | -1,505 | -1,400 |
| Investing Cash Flow | $-30,226 | $-8,303 | $-253 | $-1,505 | $-1,400 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -9,600 | -1,600 | -1,600 |
| Common Stock Issued | 1,074 | 2,055 | 3,054 | 389 | 161 |
| Other Financing Activity | 0 | 3,277 | 857 | 452 | 274 |
| Financing Cash Flow | $1,074 | $5,332 | $-5,689 | $-759 | $-1,165 |
| Exchange Rate Effect | -208 | -184 | 43 | 5 | -32 |
| Beginning Cash Position | 100,156 | 63,333 | 44,067 | 35,777 | 28,202 |
| End Cash Position | 110,707 | 100,156 | 63,333 | 44,068 | 35,777 |
| Net Cash Flow | $10,551 | $36,823 | $19,266 | $8,290 | $7,575 |
| Free Cash Flow | |||||
| Operating Cash Flow | 39,911 | 39,978 | 25,165 | 10,549 | 10,173 |
| Capital Expenditure | -9,225 | -1,553 | -441 | -1,505 | -1,400 |
| Free Cash Flow | 30,686 | 38,425 | 24,724 | 9,044 | 8,773 |